Discover free eBooks, guides and med spa templates on our new resources page

Book a demo
☰
Why us
ICD Hub / / RA00.0 - Vaping related disorder
ICD-11

ICD-11 Codes
for RA00.0 - Vaping related disorder
Teodor Jurukovski November 30, -0001
Fact checked by: Teodor Jurukovski
Use Code

Vaping related disorder, identified by the ICD-11 code RA00.0, is a condition that develops from inhaling vaporised solutions. These solutions commonly contain flavourings, and may include nicotine or other substances, when used with electronic nicotine delivery systems (ENDS) or electronic non-nicotine delivery systems (ENNDS). A key diagnostic consideration is the exclusion of infections as the primary cause of lung damage. Relevant findings often include evidence of pulmonary infiltrates on imaging. Individuals experiencing vaping related disorder may present with a range of symptoms affecting the respiratory system and general well-being. These can include:
  • Cough
  • Shortness of breath or difficulty breathing
  • Chest pain or tightness
  • Fever and chills
  • Abdominal pain
  • Nausea and vomiting
  • Unexplained weight loss
Pulmonary infiltrates, visible on chest X-rays or CT scans, are often noted in affected individuals. The primary cause of vaping related disorder is the use of e-cigarettes and vaping products. While the exact components responsible for the lung inflammation are still under investigation, a significant association has been observed with vitamin E acetate, particularly when present in THC-containing e-liquids. Inhaling heated vitamin E acetate may lead to lung damage. Anyone who vapes is susceptible, but individuals who vape THC, especially from informal sources, may face a higher risk. Diagnosing vaping related disorder (RA00.0) can be complex due to symptom overlap with other respiratory conditions. Healthcare providers typically begin by reviewing a patient's medical history, focusing on vaping habits, and conducting a physical examination, including listening to the lungs. Diagnostic tests commonly employed to confirm the condition include:
  • Blood oxygen level tests to assess oxygen saturation.
  • Imaging studies such as chest X-rays or computed tomography (CT) scans to identify lung damage.
  • Pulmonary function tests (PFTs) to evaluate lung capacity and performance.
Management of vaping related disorder focuses on reducing inflammation and supporting respiratory function. Treatment strategies may include:
  • Corticosteroids, administered via inhaler or nebulizer, to decrease inflammation in the lungs.
  • Oxygen therapy to supplement oxygen levels.
  • Mechanical ventilation for individuals with severe respiratory distress.
Crucially, cessation of vaping is paramount for recovery. While many patients show improvement with treatment, the long-term effects are still being studied. Vaping related disorder (RA00.0) is also known by several other terms, reflecting its clinical presentation and association with vaping products. These include:
  • E-cigarette, or vaping, product use associated lung injury (EVALI)
  • Dabbing related lung damage
  • Dabbing related disorder
  • Electronic cigarette related lung damage
  • Electronic cigarette related lung injury
  • Dabbing related lung injury
  • E-cigarette related disorder
Accurate documentation and coding are essential for Vaping related disorder (RA00.0). Healthcare providers should clearly document the patient's vaping history, including the type of products used and the duration of use. When reporting this condition for billing and record-keeping purposes, the ICD-11 code RA00.0 should be used. This code is specifically for conditions of uncertain aetiology and emergency use related to vaping. It is important to distinguish this from other respiratory conditions and ensure that infections have been ruled out. The official condition name, Vaping related disorder, should be used in clinical documentation.

Frequently asked questions

What is classified under ICD-11 code RA00.0?
ICD-11 code RA00.0 classifies a disorder resulting from the inhalation of vaporized solutions containing flavorants, propylene glycol, glycerin, nicotine, and other substances, through the use of electronic nicotine or non-nicotine delivery systems.
What are some synonyms for the condition coded as RA00.0 in ICD-11?
Synonyms for the condition classified under ICD-11 code RA00.0 include EVALI, dabbing related disorder, and electronic cigarette related disorder.
How is the ICD-11 code RA00.0 used for documentation?
The ICD-11 code RA00.0 is used for documenting disorders resulting from the use of electronic nicotine or non-nicotine delivery systems.
What is the scope of ICD-11 code RA00.0?
ICD-11 code RA00.0 covers disorders arising from the use of electronic nicotine delivery systems (ENDS) or electronic non-nicotine delivery systems (ENNDS).
×